Epalex is developing a novel inhaled treatment for epilepsy and migraine.
Epalex has raised $1.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Epalex is headquartered in Palo Alto, United States.
Epalex is developing a novel inhaled treatment for epilepsy and migraine.
Epalex is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epalex — Funding & Investors." VCBacked, November 9, 2025, https://www.vcbacked.co/company/epalex. Accessed August 13, 2026.
VCBacked. (2025). Epalex — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/epalex
{{cite web |title=Epalex — Funding & Investors |url=https://www.vcbacked.co/company/epalex |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated